ES2747630T3 - Métodos de tratamiento de poliposis nasal administrando un antagonista de IL-4R - Google Patents

Métodos de tratamiento de poliposis nasal administrando un antagonista de IL-4R Download PDF

Info

Publication number
ES2747630T3
ES2747630T3 ES14742021T ES14742021T ES2747630T3 ES 2747630 T3 ES2747630 T3 ES 2747630T3 ES 14742021 T ES14742021 T ES 14742021T ES 14742021 T ES14742021 T ES 14742021T ES 2747630 T3 ES2747630 T3 ES 2747630T3
Authority
ES
Spain
Prior art keywords
antibody
antigen
nasal
binding fragment
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14742021T
Other languages
English (en)
Spanish (es)
Inventor
Leda Mannent
Gianluca Pirozzi
Allen Radin
Namita Gandhi
Robert Evans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Biotechnology SAS
Regeneron Pharmaceuticals Inc
Original Assignee
Sanofi Biotechnology SAS
Regeneron Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Biotechnology SAS, Regeneron Pharmaceuticals Inc filed Critical Sanofi Biotechnology SAS
Priority claimed from PCT/US2014/043440 external-priority patent/WO2014205365A1/en
Application granted granted Critical
Publication of ES2747630T3 publication Critical patent/ES2747630T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES14742021T 2013-06-21 2014-06-20 Métodos de tratamiento de poliposis nasal administrando un antagonista de IL-4R Active ES2747630T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361837912P 2013-06-21 2013-06-21
EP14305670 2014-05-07
PCT/US2014/043440 WO2014205365A1 (en) 2013-06-21 2014-06-20 Methods for treating nasal polyposis by administering an il-4r antagonist

Publications (1)

Publication Number Publication Date
ES2747630T3 true ES2747630T3 (es) 2020-03-11

Family

ID=66440559

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14742021T Active ES2747630T3 (es) 2013-06-21 2014-06-20 Métodos de tratamiento de poliposis nasal administrando un antagonista de IL-4R

Country Status (10)

Country Link
JP (3) JP6640977B2 (hr)
DK (1) DK3010539T3 (hr)
ES (1) ES2747630T3 (hr)
HR (1) HRP20191709T1 (hr)
HU (1) HUE046410T2 (hr)
LT (1) LT3010539T (hr)
NZ (1) NZ631118A (hr)
PT (1) PT3010539T (hr)
SG (1) SG10201912898XA (hr)
TW (1) TWI707694B (hr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
US20120088814A1 (en) * 2009-03-31 2012-04-12 Isis Pharmaceuticals, Inc. Methods of modulating an immune response to a viral infection
UA111731C2 (uk) * 2010-10-06 2016-06-10 Рідженерон Фармасьютікалз, Інк. Стабілізована композиція, яка містить антитіло до рецептора інтерлейкіну-4 (іl-4r), варіанти
US10059771B2 (en) * 2013-06-21 2018-08-28 Sanofi Biotechnology Methods for treating nasal polyposis by administering an IL-4R antagonist

Also Published As

Publication number Publication date
PT3010539T (pt) 2019-10-14
TW201940193A (zh) 2019-10-16
SG10201912898XA (en) 2020-02-27
TWI707694B (zh) 2020-10-21
NZ752224A (en) 2020-11-27
HUE046410T2 (hu) 2020-03-30
DK3010539T3 (da) 2019-10-21
NZ631118A (en) 2019-05-31
LT3010539T (lt) 2019-10-10
HRP20191709T1 (hr) 2019-12-13
JP2020073525A (ja) 2020-05-14
JP2019069987A (ja) 2019-05-09
JP6640977B2 (ja) 2020-02-05
JP6898421B2 (ja) 2021-07-07
JP2021138743A (ja) 2021-09-16

Similar Documents

Publication Publication Date Title
AU2019261751B2 (en) Methods for treating nasal polyposis by administering an IL-4R antagonist
US20220204631A1 (en) Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist
ES2747630T3 (es) Métodos de tratamiento de poliposis nasal administrando un antagonista de IL-4R
JP7216122B2 (ja) Il-4rアンタゴニストの投与により鼻ポリープを伴う慢性副鼻腔炎を処置する方法
NZ752224B2 (en) Methods for treating nasal polyposis by administering an il-4r antagonist